Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression (MaMiDaPP)
Primary Purpose
Depression, Unipolar, Pain, Postoperative
Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Mindfulness
Sponsored by
About this trial
This is an interventional treatment trial for Depression, Unipolar focused on measuring postpartum, depression, pain, cesarean
Eligibility Criteria
Inclusion Criteria:
- 18-45 years of age, have a singleton pregnancy, score less than 10 on the Edinburgh Postnatal Depression Scale (EPDS; (Cox et al., 1987b), willing to participate in the eight-week intervention or be randomized to the TAUM condition, have no significant psychiatric disorders other than depression or anxiety (e.g., bipolar disorder, substance use disorder, etc.), have no chronic pain condition (e.g., fibromyalgia), and proficient in English or Spanish
Exclusion Criteria:
- Women who screen 10 or higher on the EPDS
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Mindfulness
Treatment as usual with monitoring
Arm Description
Receiving mobile, self-guided mindfulness intervention
Receiving treatment as usual with monitoring by study PI and investigators.
Outcomes
Primary Outcome Measures
Postpartum depression
depressive symptoms EPDS 13 or higher
Secondary Outcome Measures
Post-operative pain
Post-cesarean delivery pain
Full Information
NCT ID
NCT05400382
First Posted
May 27, 2022
Last Updated
May 27, 2022
Sponsor
University of Illinois at Urbana-Champaign
Collaborators
University of Pittsburgh Medical Center, Southern Illinois University, Arrowhead Regional Medical Center, Northwestern University Feinberg School of Medicine
1. Study Identification
Unique Protocol Identification Number
NCT05400382
Brief Title
Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
Acronym
MaMiDaPP
Official Title
Optimizing Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
Study Type
Interventional
2. Study Status
Record Verification Date
May 2022
Overall Recruitment Status
Not yet recruiting
Study Start Date
July 1, 2023 (Anticipated)
Primary Completion Date
March 31, 2026 (Anticipated)
Study Completion Date
March 31, 2026 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Illinois at Urbana-Champaign
Collaborators
University of Pittsburgh Medical Center, Southern Illinois University, Arrowhead Regional Medical Center, Northwestern University Feinberg School of Medicine
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.
Detailed Description
This clinical trial will test the effect of a mobile mindfulness-based intervention on reducing post-cesarean delivery pain and preventing postpartum depression.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Depression, Unipolar, Pain, Postoperative
Keywords
postpartum, depression, pain, cesarean
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
75 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Mindfulness
Arm Type
Experimental
Arm Description
Receiving mobile, self-guided mindfulness intervention
Arm Title
Treatment as usual with monitoring
Arm Type
No Intervention
Arm Description
Receiving treatment as usual with monitoring by study PI and investigators.
Intervention Type
Behavioral
Intervention Name(s)
Mindfulness
Other Intervention Name(s)
Mindfulness meditation
Intervention Description
Meditation training to help reduce stress and reactivity to pain and other stressors.
Primary Outcome Measure Information:
Title
Postpartum depression
Description
depressive symptoms EPDS 13 or higher
Time Frame
4 weeks - 6 months
Secondary Outcome Measure Information:
Title
Post-operative pain
Description
Post-cesarean delivery pain
Time Frame
4 weeks - 6 months
10. Eligibility
Sex
Female
Gender Based
Yes
Gender Eligibility Description
Cis-gender women
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
45 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
18-45 years of age, have a singleton pregnancy, score less than 10 on the Edinburgh Postnatal Depression Scale (EPDS; (Cox et al., 1987b), willing to participate in the eight-week intervention or be randomized to the TAUM condition, have no significant psychiatric disorders other than depression or anxiety (e.g., bipolar disorder, substance use disorder, etc.), have no chronic pain condition (e.g., fibromyalgia), and proficient in English or Spanish
Exclusion Criteria:
Women who screen 10 or higher on the EPDS
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Sandraluz Lara-Cinisomo, Ph.D.
Phone
217-300-3512
Email
laracini@illinois.edu
12. IPD Sharing Statement
Plan to Share IPD
Undecided
IPD Sharing Plan Description
To be determined
Learn more about this trial
Mindfulness to Reduce Post-cesarean Pain and Prevent Postpartum Depression
We'll reach out to this number within 24 hrs